Sandoz Unveils $400m+ Investment In Slovenian Biosimilars Plant
Lendava Biologics Facility Is Expected To Become Fully Operational By 2026
• By David Wallace
Sandoz has unveiled plans to invest at least $400m in a biologics production facility in Slovenia • Source: Shutterstock 
